Jacek Gan

2.5k total citations
39 papers, 2.0k citations indexed

About

Jacek Gan is a scholar working on Immunology, Oncology and Neurology. According to data from OpenAlex, Jacek Gan has authored 39 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Immunology, 19 papers in Oncology and 18 papers in Neurology. Recurrent topics in Jacek Gan's work include Neuroblastoma Research and Treatments (18 papers), CAR-T cell therapy research (11 papers) and Immunotherapy and Immune Responses (11 papers). Jacek Gan is often cited by papers focused on Neuroblastoma Research and Treatments (18 papers), CAR-T cell therapy research (11 papers) and Immunotherapy and Immune Responses (11 papers). Jacek Gan collaborates with scholars based in United States, Switzerland and Poland. Jacek Gan's co-authors include Paul M. Sondel, Jacquelyn A. Hank, Ralph A. Reisfeld, Stephen D. Gillies, Robert C. Seeger, Mark R. Albertini, Katherine K. Matthay, Mark Krailo, Jens C. Eickhoff and Gregory H. Reaman and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Jacek Gan

39 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacek Gan United States 23 986 951 950 729 362 39 2.0k
S. D. Gillies United States 13 1.4k 1.4× 872 0.9× 702 0.7× 980 1.3× 340 0.9× 18 2.2k
Hong-Fen Guo United States 25 555 0.6× 1.1k 1.1× 608 0.6× 783 1.1× 551 1.5× 50 2.0k
N K Cheung United States 17 736 0.7× 417 0.4× 531 0.6× 571 0.8× 337 0.9× 32 1.6k
Raphaël F. Rousseau United States 24 475 0.5× 758 0.8× 599 0.6× 708 1.0× 42 0.1× 56 1.8k
Gloria Balaban United States 19 398 0.4× 630 0.7× 209 0.2× 1.0k 1.4× 114 0.3× 23 1.7k
Sharon Barrans United Kingdom 21 347 0.4× 1.0k 1.1× 402 0.4× 506 0.7× 89 0.2× 54 2.3k
James D. Phelan United States 19 166 0.2× 642 0.7× 490 0.5× 519 0.7× 103 0.3× 51 1.7k
Oliver Manzke Germany 19 151 0.2× 627 0.7× 676 0.7× 552 0.8× 500 1.4× 36 1.9k
P A Bunn United States 14 134 0.1× 1.1k 1.1× 295 0.3× 478 0.7× 181 0.5× 21 1.7k
John E. Neely United States 13 283 0.3× 199 0.2× 189 0.2× 376 0.5× 193 0.5× 18 895

Countries citing papers authored by Jacek Gan

Since Specialization
Citations

This map shows the geographic impact of Jacek Gan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacek Gan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacek Gan more than expected).

Fields of papers citing papers by Jacek Gan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacek Gan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacek Gan. The network helps show where Jacek Gan may publish in the future.

Co-authorship network of co-authors of Jacek Gan

This figure shows the co-authorship network connecting the top 25 collaborators of Jacek Gan. A scholar is included among the top collaborators of Jacek Gan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacek Gan. Jacek Gan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Alice L., Andrew L. Gilman, M. Fevzi Özkaynak, et al.. (2021). Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032. Clinical Cancer Research. 27(8). 2179–2189. 132 indexed citations
2.
Albertini, Mark R., Richard K. Yang, Erik A. Ranheim, et al.. (2018). Pilot trial of the hu14.18-IL2 immunocytokine in patients with completely resectable recurrent stage III or stage IV melanoma. Cancer Immunology Immunotherapy. 67(10). 1647–1658. 36 indexed citations
3.
Wang, Wei, Amy K. Erbe, Jacek Gan, et al.. (2016). Human NK cells maintain licensing status and are subject to killer immunoglobulin-like receptor (KIR) and KIR-ligand inhibition following ex vivo expansion. Cancer Immunology Immunotherapy. 65(9). 1047–1059. 20 indexed citations
4.
Yang, Richard K., Nicholas A. Kalogriopoulos, Alexander L. Rakhmilevich, et al.. (2013). Intratumoral treatment of smaller mouse neuroblastoma tumors with a recombinant protein consisting of IL-2 linked to the Hu14.18 antibody increases intratumoral CD8+ T and NK cells and improves survival. Cancer Immunology Immunotherapy. 62(8). 1303–1313. 46 indexed citations
5.
Albertini, Mark R., Jacquelyn A. Hank, Brian Gadbaw, et al.. (2012). Phase II trial of hu14.18-IL2 for patients with metastatic melanoma. Cancer Immunology Immunotherapy. 61(12). 2261–2271. 65 indexed citations
6.
Lange, Beverly J., Richard K. Yang, Jacek Gan, et al.. (2011). Soluble interleukin‐2 receptor α activation in a Children's Oncology Group randomized trial of interleukin‐2 Therapy for Pediatric Acute Myeloid Leukemia. Pediatric Blood & Cancer. 57(3). 398–405. 7 indexed citations
7.
Sondel, Paul M., Jacquelyn A. Hank, Paul Schalch, et al.. (2005). Phase I trial of combined treatment with ch14.18 and R24 monoclonal antibodies and interleukin-2 for patients with melanoma or sarcoma. Cancer Immunology Immunotherapy. 55(7). 761–774. 20 indexed citations
8.
Connor, Joseph P., Mildred Felder, Jacquelyn A. Hank, et al.. (2004). Ex Vivo Evaluation of Anti-EpCAM Immunocytokine huKS-IL2 in Ovarian Cancer. Journal of Immunotherapy. 27(3). 211–219. 35 indexed citations
9.
Hank, Jacquelyn A., et al.. (2003). Determination of Peak Serum Levels and Immune Response to the Humanized Anti-Ganglioside Antibody-Interleukin-2 Immunocytokine. Humana Press eBooks. 85. 123–132. 10 indexed citations
10.
Kendra, Kari, Jacek Gan, Jean E. Surfus, et al.. (1999). Pharmacokinetics and stability of the ch14.18-interleukin-2 fusion protein in mice. Cancer Immunology Immunotherapy. 48(5). 219–229. 37 indexed citations
11.
12.
Frost, Jami D., Jacquelyn A. Hank, Gregory H. Reaman, et al.. (1997). A Phase I/IB trial of murine monoclonal anti-GD2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma. Cancer. 80(2). 317–333. 120 indexed citations
13.
Farner, Nancy L., Jacek Gan, Jill L. O. de Jong, et al.. (1997). ALTERATION OF THE CD34+Tf-1β CELL LINE PROFILE IN RESPONSE TO LONG-TERM EXPOSURE TO IL-15. Cytokine. 9(5). 316–327. 11 indexed citations
14.
Helfand, Stuart C., Jacquelyn A. Hank, Jacek Gan, & Paul M. Sondel. (1996). Lysis of Human Tumor Cell Lines by Canine Complement plus Monoclonal Antiganglioside Antibodies or Natural Canine Xenoantibodies. Cellular Immunology. 167(1). 99–107. 12 indexed citations
15.
Albertini, Mark R., Jacek Gan, Barry E. Storer, et al.. (1996). Systemic Interleukin-2 Modulates the Anti-Idiotypic Response to Chimeric Anti-GD2 Antibody in Patients with Melanoma. Journal of Immunotherapy. 19(4). 278–295. 24 indexed citations
16.
Helfand, Stuart C., Steve A. Soergel, Jacek Gan, et al.. (1994). Potential to Involve Multiple Effector Cells with Human Recombinant Interleukin-2 and Antiganglioside Monoclonal Antibodies in a Canine Malignant Melanoma Immunotherapy Model. Journal of Immunotherapy. 16(3). 188–197. 18 indexed citations
17.
York, Dona, В. П. Иванов, Jacek Gan, & Marcin Filutowicz. (1992). Translational options for the pir gene of plasmid R6K: multiple forms of the replication initiator protein π. Gene. 116(1). 7–12. 14 indexed citations
18.
Narkiewicz, Krzysztof, et al.. (1991). Relationship between fasting plasma insulin and ambulatory blood pressure in young, non-obese normotensive subjects. Journal of Hypertension. 9(6). 505–507. 14 indexed citations
19.
Bręborowicz, J, et al.. (1987). Affinity electrophoresis with monoclonal antibodies. Electrophoresis. 8(7). 313–318. 6 indexed citations
20.
Bręborowicz, J, et al.. (1987). Application of monoclonal antibodies for affinity electrophoresis. Journal of Immunological Methods. 102(1). 101–107. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. D. Gillies Breakdown of academic impact, for papers by Hong-Fen Guo Breakdown of academic impact, for papers by N K Cheung Breakdown of academic impact, for papers by Raphaël F. Rousseau Breakdown of academic impact, for papers by Gloria Balaban Breakdown of academic impact, for papers by Sharon Barrans Breakdown of academic impact, for papers by James D. Phelan Breakdown of academic impact, for papers by Oliver Manzke Breakdown of academic impact, for papers by P A Bunn Breakdown of academic impact, for papers by John E. Neely
Rankless by CCL
2026